{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:46:54Z","timestamp":1772192814936,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,24]]},"DOI":"10.7759\/cureus.90861","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T09:29:46Z","timestamp":1756027786000},"source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Study of the Temporal Trends in Mortality in Patients With Non-alcoholic Fatty Liver Disease and Liver Cirrhosis in the United States Using the Centers for Disease Control and Prevention's (CDC) Multiple Causes of Death (MCD) Database"],"prefix":"10.7759","author":[{"given":"Vinutna Muvva","family":"Kolluri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aayushi","family":"Bhamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinmay","family":"Gohel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowri","family":"Bindu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepthi","family":"Enumula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease - meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani N","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012, 55:2005-23. 10.1002\/hep.25762","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter TG","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020, 158:1851-64. 10.1053\/j.gastro.2020.01.052","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne CD","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015, 62:S47-64. 10.1016\/j.jhep.2014.12.012","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-021-00373-7","article-title":"Liver regeneration and inflammation: from fundamental science to clinical applications","volume":"22","author":"Campana L","year":"2021","unstructured":"Campana L, Esser H, Huch M, Forbes S. Liver regeneration and inflammation: from fundamental science to clinical applications. Nat Rev Molec Cell Biol. 2021, 22:608-24.","journal-title":"Nat Rev Molec Cell Biol"},{"key":"ref6","article-title":"","author":"Cirrhosis in Over 16s: assessment and management","year":"2023","unstructured":"Cirrhosis in Over 16s. assessment and management: NICE Clinical Guidelines No. 50. National Institute for Health and Care Excellence, London; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK595473\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi H","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023, 79:516-37. 10.1016\/j.jhep.2023.03.017","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh S","year":"2015","unstructured":"Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015, 13:643-54.e1-9. 10.1016\/j.cgh.2014.04.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2784537","article-title":"Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis","volume":"2018","author":"Li B","year":"2018","unstructured":"Li B, Zhang C, Zhan YT. Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol. 2018, 2018:2784537. 10.1155\/2018\/2784537","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref10","unstructured":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. CDC WONDER Online Database, Multiple Cause of Death Files. ( 1999). http.\/\/wonder.cdc.gov."},{"key":"ref11","article-title":"Using routinely collected health data for surveillance, quality improvement and research: Framework and key questions to assess ethics and privacy and enable data access","volume":"22","author":"De Lusignan S","year":"2015","unstructured":"De Lusignan S, Liyanage H, Di Iorio CT, Chan T, Liaw ST. Using routinely collected health data for surveillance, quality improvement and research: Framework and key questions to assess ethics and privacy and enable data access. BMJ Health & Care Informatics. 2015, 22:","journal-title":"BMJ Health & Care Informatics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042220-020407","article-title":"Fatty liver disease: diagnosis and stratification","volume":"73","author":"Saiman Y","year":"2022","unstructured":"Saiman Y, Duarte-Rojo A, Rinella ME. Fatty liver disease: diagnosis and stratification. Annu Rev Med. 2022, 73:529-44. 10.1146\/annurev-med-042220-020407","journal-title":"Annu Rev Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels S","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, et al.. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022, 22:63. 10.1186\/s12902-022-00980-1","journal-title":"BMC Endocr Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera V","year":"2021","unstructured":"Ajmera V, Loomba R. Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab. 2021, 50:101167. 10.1016\/j.molmet.2021.101167","journal-title":"Mol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.08.006","article-title":"ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2\/ERK signaling pathways","volume":"47","author":"Zhang Z","year":"2023","unstructured":"Zhang Z, Yuan Y, Hu L, et al.. ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2\/ERK signaling pathways. J Adv Res. 2023, 47:41-56. 10.1016\/j.jare.2022.08.006","journal-title":"J Adv Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou GN","year":"2021","unstructured":"Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol. 2021, 75:1476-84. 10.1016\/j.jhep.2021.08.012","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094495","article-title":"Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC","volume":"22","author":"Kim H","year":"2021","unstructured":"Kim H, Lee DS, An TH, Park HJ, Kim WK, Bae KH, Oh KJ. Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC. Int J Mol Sci. 2021, 22:4495. 10.3390\/ijms22094495","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang DQ","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021, 18:223-38.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082986","article-title":"Nutrition and genetics in NAFLD: the perfect binomium","volume":"21","author":"Meroni M","year":"2020","unstructured":"Meroni M, Longo M, Rustichelli A, Dongiovanni P. Nutrition and genetics in NAFLD: the perfect binomium. Int J Mol Sci. 2020, 21:2986. 10.3390\/ijms21082986","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza S","year":"2021","unstructured":"Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD\/NASH. Front Biosci (Landmark Ed). 2021, 26:206-37. 10.2741\/4892","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024, 81.492-542. 10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394063-a-retrospective-study-of-the-temporal-trends-in-mortality-in-patients-with-non-alcoholic-fatty-liver-disease-and-liver-cirrhosis-in-the-united-states-using-the-centers-for-disease-control-and-preventions-cdc-multiple-causes-of-death-mcd-database","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T09:29:47Z","timestamp":1756027787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394063-a-retrospective-study-of-the-temporal-trends-in-mortality-in-patients-with-non-alcoholic-fatty-liver-disease-and-liver-cirrhosis-in-the-united-states-using-the-centers-for-disease-control-and-preventions-cdc-multiple-causes-of-death-mcd-database"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.90861","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,24]]}}}